The association of family history of herpes zoster and the risk of incident herpes zoster: the SHEZ Study.

Family history Herpes zoster History of HZ Incidence Prospective cohort study

Journal

Environmental health and preventive medicine
ISSN: 1347-4715
Titre abrégé: Environ Health Prev Med
Pays: Japan
ID NLM: 9609642

Informations de publication

Date de publication:
2022
Historique:
entrez: 1 6 2022
pubmed: 2 6 2022
medline: 7 6 2022
Statut: ppublish

Résumé

We investigated whether family histories of herpes zoster (HZ) are associated with the risk of incident HZ in a Japanese population. A total of 12,522 Japanese residents aged ≥50 years in Shozu County participated in the baseline survey between December 2008 and November 2009 (the participation rate = 72.3%). They were interviewed at baseline by research physicians regarding the registrants' history of HZ. A self-administered questionnaire survey was conducted to evaluate the potential confounding factors. 10,530 participants without a history of HZ were followed up to ascertain the incidence of HZ during 3-years follow-up until the end of November 2012 with Japanese nationals. We estimated hazard ratios (HRs) of incident HZ according to first-degree family histories using the Cox proportional hazard regression after adjusting for age, sex, and other potential confounding factors. Compared to no HZ history of each family member, a history of brother or sister was associated with a higher risk of incident HZ while histories of father and mother were not. The multivariable HR (95%CI) of incident HZ for a history of brother or sister was 1.67 (1.04-2.69). When comparing to no family histories of all first-degree relatives, the multivariable HRs (95%CIs) were 1.34 (0.77-2.34) for a history of brother or sister alone, but 4.81 (1.78-13.00) for a history of mother plus brother or sister. As for the number of family histories, the multivariable HRs (95%CIs) were 1.08 (0.76-1.54) for one relative (father, mother, or brother or sister) and 2.75 (1.13-6.70) for two or more relatives. Family histories of mother plus brother or sister and two or more first-degree relatives were associated with a higher risk of incident HZ.

Sections du résumé

BACKGROUND
We investigated whether family histories of herpes zoster (HZ) are associated with the risk of incident HZ in a Japanese population.
METHODS
A total of 12,522 Japanese residents aged ≥50 years in Shozu County participated in the baseline survey between December 2008 and November 2009 (the participation rate = 72.3%). They were interviewed at baseline by research physicians regarding the registrants' history of HZ. A self-administered questionnaire survey was conducted to evaluate the potential confounding factors. 10,530 participants without a history of HZ were followed up to ascertain the incidence of HZ during 3-years follow-up until the end of November 2012 with Japanese nationals. We estimated hazard ratios (HRs) of incident HZ according to first-degree family histories using the Cox proportional hazard regression after adjusting for age, sex, and other potential confounding factors.
RESULTS
Compared to no HZ history of each family member, a history of brother or sister was associated with a higher risk of incident HZ while histories of father and mother were not. The multivariable HR (95%CI) of incident HZ for a history of brother or sister was 1.67 (1.04-2.69). When comparing to no family histories of all first-degree relatives, the multivariable HRs (95%CIs) were 1.34 (0.77-2.34) for a history of brother or sister alone, but 4.81 (1.78-13.00) for a history of mother plus brother or sister. As for the number of family histories, the multivariable HRs (95%CIs) were 1.08 (0.76-1.54) for one relative (father, mother, or brother or sister) and 2.75 (1.13-6.70) for two or more relatives.
CONCLUSION
Family histories of mother plus brother or sister and two or more first-degree relatives were associated with a higher risk of incident HZ.

Identifiants

pubmed: 35644539
doi: 10.1265/ehpm.21-00020
pmc: PMC9251617
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

22

Références

J Clin Virol. 2011 Dec;52(4):344-8
pubmed: 21924676
BMC Infect Dis. 2017 May 9;17(1):334
pubmed: 28486993
Infection. 2008 Jun;36(3):226-30
pubmed: 18454342
J Epidemiol. 2021 Feb 13;:
pubmed: 33583935
J Res Health Sci. 2014 Spring;14(2):111-4
pubmed: 24728744
J Dermatol Sci. 2007 Mar;45(3):213-5
pubmed: 17204399
Eur J Hum Genet. 2007 Jun;15(6):672-8
pubmed: 17356546
Clin Infect Dis. 2001 May 15;32(10):1481-6
pubmed: 11317250
Clin Infect Dis. 2009 May 15;48(10):1364-71
pubmed: 19368499
Fam Pract. 2002 Oct;19(5):471-5
pubmed: 12356697
Int J Infect Dis. 2018 Jan;66:99-106
pubmed: 29146515
Br J Cancer. 2017 Jun 6;116(12):1643-1651
pubmed: 28463961
Open Forum Infect Dis. 2016 Jun 11;3(3):ofw119
pubmed: 27382600
J Clin Virol. 2012 Oct;55(2):153-7
pubmed: 22824229
Arch Dermatol. 2008 May;144(5):603-8
pubmed: 18490586
Am J Epidemiol. 2018 Feb 1;187(2):251-259
pubmed: 29036443
Am J Epidemiol. 2021 Jun 1;190(6):1064-1074
pubmed: 33569573
J Epidemiol. 2012;22(2):167-74
pubmed: 22343323
Epidemiol Infect. 2017 Apr;145(6):1270-1275
pubmed: 28091339

Auteurs

Keiko Kinumaki (K)

Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine.

Hironori Imano (H)

Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine.

Yukiko Takao (Y)

Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine.

Yoshinobu Okuno (Y)

Research Institute for Microbial Diseases, Osaka University.

Yasuko Mori (Y)

Division of Clinical Virology, Kobe University Graduate School of Medicine.

Hideo Asada (H)

Department of Dermatology, Nara Medical University School of Medicine.

Koichi Yamanishi (K)

The Research Foundation for Microbial Diseases of Osaka University.

Hiroyasu Iso (H)

Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH